Progenics reports wider loss
-
- November
- 8
Progenics Pharmaceuticals Inc., an Eastview-based biotech research company, reported this morning it lost $15.6 million, or 58 cents a share, during the third quarter, compared with a loss of $2.94 million, or 11 cents a share, a year earlier. Revenues were down to $17.02 million from $17.85 million.
This entry was posted
on Thursday, November 8th, 2007 at 10:31 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Category: Corporate doings
Print
|
Email
Leave a Reply
It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the
Terms of Service.